EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign

Shumpei Onishi, Fumiyuki Yamasaki, Yuji Akiyama, Daisuke Kawahara, Vishwa Jeet Amatya, Ushio Yonezawa, Akira Taguchi, Iori Ozono, Novita Ikbar Khairunnisa, Yukio Takeshima, Nobutaka Horie

Journal of Neuro-Oncology · 2024-11 · 170 (2) · 429-436

DOI: 10.1007/s11060-024-04794-0 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 12.08.2024. Verfasst von Shumpei Onishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima-city, Hiroshi…. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Brain Neoplasms, Magnetic Resonance Imaging, Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hiroshima University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The T2-FLAIR mismatch sign is a characteristic imaging biomarker for astrocytoma, isocitrate dehydrogenase (IDH)-mutant. However, investigators have provided varying interpretations of the positivity/negativity of this sign given for individual cases the nature of qualitative visual assessment. Moreover, MR sequence parameters also influence the appearance of the T2-FLAIR mismatch sign. To resolve these issues, we used synthetic MR technique to quantitatively evaluate and differentiate astrocytoma from oligodendroglioma.

Methods

This study included 20 patients with newly diagnosed non-enhanced IDH-mutant diffuse glioma who underwent preoperative synthetic MRI using the Quantification of Relaxation Times and Proton Density by Multiecho acquisition of a saturation-recovery using Turbo spin-Echo Readout (QRAPMASTER) sequence at our institution. Two independent reviewers evaluated preoperative conventional MR images to determine the presence or absence of the T2-FLAIR mismatch sign. Synthetic MRI was used to measure T1, T2 and proton density (PD) values in the tumor lesion. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance.

Results

The pathological diagnoses included astrocytoma, IDH-mutant ( n = 12) and oligodendroglioma, IDH-mutant and 1p/19q-codeleted ( n = 8). The sensitivity and specificity of T2-FLAIR mismatch sign for astrocytoma were 66.7% and 100% [area under the ROC curve (AUC) = 0.833], respectively. Astrocytoma had significantly higher T1, T2, and PD values than did oligodendroglioma ( p < 0.0001, < 0.0001, and 0.0154, respectively). A cutoff lesion T1 value of 1580 ms completely differentiated astrocytoma from oligodendroglioma (AUC = 1.00).

Conclusion

Quantitative evaluation of non-enhanced IDH-mutant diffuse glioma using synthetic MRI allowed for better differentiation between astrocytoma and oligodendroglioma than did conventional T2-FLAIR mismatch sign. Measurement of T1 and T2 value by synthetic MRI could improve the differentiation of IDH-mutant diffuse gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isocitrate DehydrogenaseBrain NeoplasmsMagnetic Resonance ImagingMutationGliomaHumansFemaleMaleMiddle AgedAdultAgedDiagnosis, DifferentialYoung AdultROC CurveRetrospective Studies

Stichwörter der Autor:innen

AstrocytomaDiffuse gliomaIDH-mutantSynthetic MRIT2-FLAIR mismatch sign

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima-city, Hiroshima, 734-8551, Japan.
  • Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima-city, Hiroshima, 734-8551, Japan. fyama@hiroshima-u.ac.jp.
  • Department of Clinical Radiology, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Förderung

  • Hiroshima University

Zitieren

APA

Onishi, S., Yamasaki, F., Akiyama, Y., Kawahara, D., Amatya, V. J., Yonezawa, U., Taguchi, A., Ozono, I., Khairunnisa, N. I., Takeshima, Y., & Horie, N. (2024). Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign. Journal of Neuro-Oncology, 170(2), 429-436. https://doi.org/10.1007/s11060-024-04794-0

Vancouver

Onishi S, Yamasaki F, Akiyama Y, Kawahara D, Amatya VJ, Yonezawa U, et al. Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign. Journal of Neuro-Oncology. 2024;170(2):429-436. doi:10.1007/s11060-024-04794-0

BibTeX
@article{Onishi2024,
  author = {Onishi, Shumpei and Yamasaki, Fumiyuki and Akiyama, Yuji and Kawahara, Daisuke and Amatya, Vishwa Jeet and Yonezawa, Ushio and Taguchi, Akira and Ozono, Iori and Khairunnisa, Novita Ikbar and Takeshima, Yukio and Horie, Nobutaka},
  title = {Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  volume = {170},
  number = {2},
  pages = {429--436},
  doi = {10.1007/s11060-024-04794-0}
}
Kostenlos starten →